Mr. Dixon Griffin Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7716 W Manchester Ave, Playa Del Rey, CA 90293 Phone: 310-823-4694 Fax: 310-822-1260 |
Rithya Kim, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7716 W Manchester Ave, Playa Del Rey, CA 90293 Phone: 310-823-4694 |
Tanya Lynn Balakrishnan, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 8131 Billowvista Dr, Playa Del Rey, CA 90293 Phone: 310-721-2955 |
Ethan Waldman Physical Therapy & Wellness Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 8107 Delgany Ave, Playa Del Rey, CA 90293 Phone: 310-720-6799 |
Lauren Goodell, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 211 Culver Blvd, Suite K, Playa Del Rey, CA 90293 Phone: 310-665-0103 Fax: 888-836-6934 |
Karen Fradkin, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6308 Vista Del Mar Apt A, Playa Del Rey, CA 90293 Phone: 404-434-7774 Fax: 323-300-2036 |
Dr. Desiree Janine Williams, DPT Physical Therapist - Orthopedic Medicare: Accepting Medicare Assignments Practice Location: 6308 Vista Del Mar Apt A, Playa Del Rey, CA 90293 Phone: 404-434-7774 |
Compete Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8180 Manitoba St Apt 340, Playa Del Rey, CA 90293 Phone: 626-230-3940 |
Yvonne Leichter Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8327 Pershing Dr, Playa Del Rey, CA 90293 Phone: 310-871-4658 |
Melissa Comeau Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7716 W Manchester Ave, Playa Del Rey, CA 90293 Phone: 310-823-4694 |
News Archive
Researchers from Mahidol University have developed a rapid, high-throughput screening method for prevention and control of thalassemia. The related report by Munkongdee et al, "Rapid diagnosis of α-thalassemia by melting curve analysis," appears in the May 2010 issue of The Journal of Molecular Diagnostics.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company's two ongoing stem cell clinical trials in the United States authorized ACT to move forward with enrolling and treating the next set of patients in each of the trials.
Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that a major European medical center, Hospital Germans Trias i Pujol in Barcelona Spain, is now using the company's Presage ST2 Assay for routine care and management of their heart failure patients.
Watson Pharmaceuticals, Inc. and Columbia Laboratories, Inc. today confirmed that, as expected, Watson has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA 22-139) for progesterone vaginal gel 8% for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy.
› Verified 6 days ago